Difference between revisions of "Danaparoid (Orgaran)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
Line 15: Line 15:
 
[[Category:Low molecular weight heparins]]
 
[[Category:Low molecular weight heparins]]
  
 +
[[Category:Heparin-induced thrombocytopenia medications]]
 
[[Category:Venous thromboembolism (VTE) medications]]
 
[[Category:Venous thromboembolism (VTE) medications]]
  
 
[[Category:FDA approved in 2001]]
 
[[Category:FDA approved in 2001]]
 
[[Category:Discontinued drugs]]
 
[[Category:Discontinued drugs]]

Revision as of 19:39, 27 February 2019

General information

Class/mechanism: Low molecular weight heparin

History of changes in FDA indication

  • 6/26/2001: Initial FDA approval

Also known as

  • Brand name: Orgaran